KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $16.79 $21.89 Friday, 26th Apr 2024 KURA stock ended at $19.65. This is 3.42% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.01% from a day low at $18.95 to a day high of $19.71.
90 days $16.79 $24.16
52 weeks $7.41 $24.16

Historical Kura Oncology prices

Date Open High Low Close Volume
Mar 21, 2024 $22.14 $22.82 $21.27 $21.35 560 339
Mar 20, 2024 $21.25 $22.25 $21.25 $21.94 831 227
Mar 19, 2024 $20.99 $21.76 $20.65 $21.69 1 050 639
Mar 18, 2024 $22.22 $22.22 $20.90 $21.04 850 113
Mar 15, 2024 $21.94 $22.97 $21.92 $22.34 3 013 503
Mar 14, 2024 $22.54 $22.76 $21.72 $21.98 1 141 267
Mar 13, 2024 $22.35 $23.02 $22.35 $22.83 665 697
Mar 12, 2024 $22.74 $22.94 $21.56 $22.31 968 512
Mar 11, 2024 $23.53 $24.16 $22.78 $22.82 1 200 292
Mar 08, 2024 $22.64 $23.66 $22.37 $23.53 1 117 379
Mar 07, 2024 $23.09 $23.75 $21.87 $22.26 1 159 135
Mar 06, 2024 $21.31 $23.13 $21.23 $22.70 1 577 366
Mar 05, 2024 $21.17 $21.51 $20.74 $21.04 466 792
Mar 04, 2024 $21.73 $21.77 $21.08 $21.31 516 978
Mar 01, 2024 $21.13 $21.96 $21.07 $21.59 772 734
Feb 29, 2024 $21.71 $21.95 $20.74 $21.08 672 200
Feb 28, 2024 $21.75 $22.53 $21.35 $21.38 1 634 243
Feb 27, 2024 $20.89 $21.93 $20.63 $21.76 1 053 060
Feb 26, 2024 $20.22 $21.03 $20.22 $20.74 529 168
Feb 23, 2024 $19.71 $20.67 $19.58 $20.25 565 303
Feb 22, 2024 $20.21 $20.28 $19.26 $19.59 781 632
Feb 21, 2024 $20.06 $20.39 $19.55 $19.99 545 788
Feb 20, 2024 $20.50 $21.89 $19.47 $20.28 1 847 337
Feb 16, 2024 $20.41 $20.64 $20.07 $20.62 512 540
Feb 15, 2024 $19.77 $20.63 $19.77 $20.51 713 305
Click to get the best stock tips daily for free!

About Kura Oncology

Kura Oncology Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, includi... KURA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT